blocks (PEO−PPO−PEO). Pluronic F127 has been approved
by FDA as a human-use cytocompatible biomaterial.187 It
shows polymer concentration-dependent thermoreversible sol−
gel transition. Above a critical micelle
Cortactin C6987 P y y y
185 Corticotropin Releasing Factor C5348 P y y y
186 COX II C9354 M y n/d n/d
187 Crk-L C0978 P y y n/d
188 Crk II C0853 P y y n/d
189 Csk C7863 P y n/d y
190
blocks (PEO−PPO−PEO). Pluronic F127 has been approved
by FDA as a human-use cytocompatible biomaterial.187 It
shows polymer concentration-dependent thermoreversible sol−
gel transition. Above a critical micelle
CRH NP_000747.1,NP_991338.1,NP_112281.1 P y y y
186 COX II C9354 5743 PTGS2 NP_000954.1 M y n/d n/d
187 Crk-L C0978 1399, 12929 CRKL,Crkl NP_005198.1,NP_031790.2 P y y n/d
188 Crk II C0853 12928, 1398 Crk
CRH NP_000747.1,NP_991338.1,NP_112281.1 P y y y
186 COX II C9354 5743 PTGS2 NP_000954.1 M y n/d n/d
187 Crk-L C0978 1399, 12929 CRKL,Crkl NP_005198.1,NP_031790.2 P y y n/d
188 Crk II C0853 12928, 1398 Crk
cDNA (activated) in pUSEamp TFX 5 µg 21-189
RalA cDNA (dominant negative) in pUSEamp TFX 5 µg 21-187
RalA cDNA (wt) in pUSEamp TFX 5 µg 21-190
Ran
Antibody
Ran H Xn WB IP IC antiserum Rb